Skip to main content
Terug
Watch Compare

60 DEGREES PHARMACEUTICALS, INC.

Datakwaliteit: 100%
Ook genoteerd als SXTPW NASDAQ
SXTP
NASDAQ Manufacturing Chemicals
€ 1,76
▲ € 0,02 (1,15%)
Marktkapitalisatie: 4,59 M
Prijs
€ 1,74
Marktkapitalisatie
4,59 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -6,99 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)65,49%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-214,78%
Onder sectorgemiddelde (-54,01%)
ROIC-175,55%
Net Margin-732,51%
Op. Margin-771,64%

Veiligheid

Debt / Equity
0,03
Onder sectorgemiddelde (0,30)
Current Ratio2,87
Interest Coverage-994,05

Waardering

PE (TTM)
-0,62
Boven sectorgemiddelde (-1,49)
P/B Ratio1,04
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -0,6 -1,5
P/B 1,0 1,6
ROE % -214,8 -54,0
Net Margin % -732,5 -41,5
Rev Growth 5Y % — 1,8
D/E 0,0 0,3

Koersdoel Analisten

2 analisten
Buy
Huidig
€ 1,76
+701.1%
Koersdoel
€ 14,10
€ 4,20
€ 14,10
€ 24,00
Vooruitzicht
Forward WPA -€ 2,16
Omzet Sch. 2,80 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 2,16
-€ 2,16 – -€ 2,16
 2,80 M 1
FY2026 -€ 3,18
-€ 3,18 – -€ 3,18
 1,90 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 2,00 -€ 8,17 -308,6%
Q32025 -€ 1,84 -€ 2,53 -37,6%
Q22025 -€ 4,96 -€ 4,33 +12,8%
Q12025 -€ 5,28 -€ 5,96 -12,9%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 65,49% Revenue Growth (3Y) 99,13%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,01 M Net Income (TTM) -7,37 M
ROE -214,78% ROA -135,50%
Gross Margin 22,26% Operating Margin -771,64%
Net Margin -732,51% Free Cash Flow (TTM) -6,99 M
ROIC -175,55% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,03 Current Ratio 2,87
Interest Coverage -994,05 Asset Turnover 0,19
Working Capital 4,11 M Tangible Book Value 4,28 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,62 Forward P/E N/A
P/B Ratio 1,04 P/S Ratio 4,56
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1,64 Fwd Earnings Yield N/A
FCF Yield -152,33%
Market Cap 4,59 M Enterprise Value 622.234,0
Per Share
EPS (Diluted TTM) -11,73 Revenue / Share 0,38
FCF / Share -2,65 OCF / Share -2,60
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 13,91% FCF Conversion 94,89%
SBC-Adj. FCF -6,92 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 1,01 M 607.574,0 253.573,0
Net Income -7,37 M -7,95 M -3,77 M
EPS (Diluted) -11,73 -18,55 -0,99
Gross Profit 223.776,0 222.809,0 -220.977,0
Operating Income -7,76 M -9,71 M -5,15 M
EBITDA — — —
R&D Expenses 2,11 M 4,99 M 691.770,0
SG&A Expenses — — —
D&A 43.324,0 11.726,0 —
Interest Expense 7.805,0 0,0 2,29 M
Income Tax 0,0 250,0 250,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 5,37 M 5,76 M 7,78 M
Total Liabilities 1,99 M 1,80 M 2,99 M
Shareholders' Equity 3,46 M 4,04 M 4,87 M
Total Debt 150.000,0 200.000,0 150.000,0
Cash & Equivalents 1,51 M 1,66 M —
Current Assets 4,90 M 5,39 M 7,24 M
Current Liabilities 1,84 M 1,66 M 2,84 M